RSS

Kymab

Kymab and Heptares Therapeutics have entered a strategic collaboration to discover, develop and commercialise novel antibody therapeutics targeting a number of G protein-coupled receptors (GPCR) with an initial focus on immuno-oncology. more

News

Pharma companies have been teaming up in the fight against cancer. EPM lists the top 5 cancer fighting collaborations more

Opinion

Kymab and MD Anderson Cancer Centre have announced a strategic cancer drug discovery and development alliance more

News

Kymab, a Cambridge-based antibodies-to-medicines company, is featured in the top ten of The Sunday Times Tech Track ‘Ones to Watch’ 2015 list more

News

Team effort: Drug discovery partnership to produce an antibody-based medicine to fight Ebola infection more

News